Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-23391158_ITM" title="Facts and information about Manufacturing, marketing and distribution agreements between biotech and pharmaceutical companies.">Manufacturing, marketing and distribution agreements between biotech and pharmaceutical companies.</a>
Manufacturing, marketing and distribution agreements between biotech and pharmaceutical companies.
Bioworld Financial Watch
|
May 26, 2003 |
COPYRIGHT 2003 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright
Manufacturing, Marketing And Distribution Agreements Between Biotech And
Pharmaceutical Companies: March 25 -- May 21, 2003 #
Biotech Co. * Pharma Co.
(Country; Symbol) (Country)
Bioenvision Inc. Penn Pharmaceutical
(OTC BB: BIOV) Services Ltd. (UK)
BioTime Inc. CJ Corp.
(AMEX:BTX) (South Korea)
Celgene Corp. GlaxoSmithKline plc
(CELG) (UK)
Eyetech Pharmaecuticals Inc. * Pfizer Inc.
Labopharm Inc. Gruppo Angelini
(Canada; TSE:DDS) (Italy) and Esteve
SA (Spain)
TolerRx Inc. * Laureate Pharma LP
United Therapeutics Corp. Caremark Inc.
(UTHR)
Biotech Co. * Product
(Country; Symbol)
Bioenvision Inc. Clofarabine
(OTC BB: BIOV)
BioTime Inc. Hextend and PentaLyte
(AMEX:BTX) blood plasma volume
expanders
Celgene Corp. Alkeran
(CELG)
Eyetech Pharmaecuticals Inc. * Xalatan
Labopharm Inc. A once-daily version of the
(Canada; TSE:DDS) analgesic tramadol
TolerRx Inc. * Monoclonal antibodies
United Therapeutics Corp. Remodulin
(UTHR)
Biotech Co. * Terms/Details (Date)
(Country; Symbol)
Bioenvision Inc. Penn Pharmaceutical will
(OTC BB: BIOV) label, package, store and
distribute clofarabine in
Europe (5/15)
BioTime Inc. Exclusive licensing agreement
(AMEX:BTX) for CJ to manufacture and sell
the expanders in South Korea
for human therapeutic uses;
...
Related articles from newspapers, magazines, journals, and more

- Beacon Equity Research reports on the OTC and OTCBB Trade Leaders: Chemokine...
- Press release article from: M2 Presswire January 9, 2008 700+ words
...Leaders: Chemokine Therapeutics Corp. (OTCBB: CHKT...beaconequityresearch.com Chemokine Therapeutics Corp. (OTCBB: CHKT...II Study Chemokine Therapeutics Corp. (the "Company...Acro, Inc. (OTC BB:ACRI), a leading...

- Stem Cell Therapeutics Corp. to Present at BioFinance 2005.
- Press release article from: PR Newswire May 12, 2005 700+ words
...Tucker, President and CEO of Stem Cell Therapeutics Corp. ("SCT"), will present a corporate...Trinity V conference room. About Stem Cell Therapeutics Corp.: Stem Cell Therapeutics Corp. is a biotechnology company focused...

- (OTCBB:CHKT) Chemokine Therapeutics Corp. just released some important news.
- Press release article from: M2 Presswire October 29, 2008 700+ words
...com: (OTCBB:CHKT) Chemokine Therapeutics Corp. just released some important news...29102008 (OTCBB:CHKT) Chemokine Therapeutics Corp. - Chemokine Therapeutics Announces...Room for (OTCBB:CHKT) Chemokine Therapeutics Corp. has been created at STOCKWIRE...

- Genome Therapeutics Corp. and Creighton University Enter Into Collaboration to...
- Press release article from: PR Newswire April 15, 1997 700+ words
...April 15 /PRNewswire/ -- Genome Therapeutics Corp. (Nasdaq: GENE) (GTC) today...Hennessey, Chairman and CEO, Genome Therapeutics Corp. "This alliance represents a material...Chief Scientific Officer, Genome Therapeutics Corp. "Instead of identifying genes...

- United Therapeutics Corp is Added to the Bellwether Watch list.
- Press release article from: M2 Presswire February 20, 2007 700+ words
...February 2007-Biotech News: United Therapeutics Corp is Added to the Bellwether Watch...COMMUNICATIONS LTD RDATE:20022007 United Therapeutics Corp (NASDAQ:UTHR) is Added to the...up to date information on United Therapeutics Corp are invited to sign up for a free...

- Stem Cell Therapeutics Corp. and Medicon A/S initiate dosing of patients in...
- Press release article from: PR Newswire November 29, 2005 700+ words
...PRNewswire-FirstCall/ -- Stem Cell Therapeutics Corp. ("SCT") is pleased to announce...point in the evolution of Stem Cell Therapeutics Corp. from a pre-clinical research...thorough QT-trials. About Stem Cell Therapeutics Corp.: Stem Cell Therapeutics Corp...

- Stem Cell Therapeutics Corp. Reports Second Quarter 2005 Results.
- Press release article from: PR Newswire August 23, 2005 700+ words
...PRNewswire-FirstCall/ -- Stem Cell Therapeutics Corp. ("SCT") today announced its financial...our development plan. About Stem Cell Therapeutics Corp.: Stem Cell Therapeutics Corp. is a biotechnology company focused...

- Global Market Perspective Review on Chemokine Therapeutics Corp. - Update...
- Press release article from: M2 Presswire January 17, 2007 700+ words
...Market Perspective Review on Chemokine Therapeutics Corp. - Update Report(C)1994-2007...Tuesday, investors of Chemokine Therapeutics Corp. (TSX:CTI) were able to secure...surrounding the aforementioned Chemokine Therapeutics Corp, which we feel may have had an effect...

- Stem Cell Therapeutics Corp. Shareholders Approve Resolutions at its First...
- Press release article from: PR Newswire May 10, 2005 700+ words
...PRNewswire-FirstCall/ -- Stem Cell Therapeutics Corp. ("SCT") announced the results of...paid to the auditors. About Stem Cell Therapeutics Corp.: Stem Cell Therapeutics Corp. is a biotechnology company focused...

- Stem Cell Therapeutics Corp. and Medicon A/S Sign Contract to Perform Phase I...
- Press release article from: PR Newswire September 29, 2005 700+ words
...PRNewswire-FirstCall/ -- Stem Cell Therapeutics Corp. ("SCT") announced today that they...thorough QT-trials. About Stem Cell Therapeutics Corp.: Stem Cell Therapeutics Corp. is a biotechnology company focused...
For more facts and information, see all results
Source: HighBeam Research, Manufacturing, marketing and distribution agreements between biotech...